Global private equity firm The Carlyle Group announced today it has raised US $668 million for Carlyle Asia Growth Partners III (CAGP), which invests in promising private companies at an expansionary stage with solid growth track records across industry sectors in China, India, Japan and Korea.
Three investments have already been made out of the new fund, including US$20 million in Claris Lifesciences (a fast growing pharmaceutical company in India), US$25 million in Credit Orienwise (the largest private credit guarantee company in China) and US$27.5 million in Anxin Flooring (the number one manufacturer and distributor of solid wood flooring in China).
Carlyle Asia Growth Partners is the third fund managed by the Carlyle Asia Growth Capital group, which has an aggregate committed capital of approximately US$1 billion, under the leadership of Managing Director Wayne Wen-Tsui Tsou.
The group invests through a team of local professionals in six offices - Beijing, Hong Kong, Mumbai, Shanghai, Seoul and Tokyo.
In addition to CAGP, the group also manages Carlyle Asia Venture Partners I (US$159 million) and II (US$164 million), which were launched in 2000 and 2002, respectively. Together, the two earlier funds have invested in 37 companies and realized 12 investments.
“Carlyle is among the first movers to make such growth capital investments. We look for companies with outstanding management and track record, differentiating and provenbusiness models, as well as large potential markets.